Post by Amylyx Pharmaceuticals
75,445 followers
We’re pleased to announce the launch of a U.S. expanded access program (EAP) for post-bariatric hypoglycemia (PBH). See today’s press release for more information: https://bit.ly/42LEzZh Additional information about the EAP is available at https://lnkd.in/eQy5qbi6.
Video Content